With MRI playing an increasingly prominent role in MCI research, Dr. Petrella predicted that increased knowledge about the effects of APOE will improve the design and execution of future clinical trials.
Researchers could enrich their samples with ε4 patients in MCI prevention trials to better determine potential treatment effects on brain regions vulnerable to degeneration.